EVO - Evotec and Owkin enter AI-powered partnership to accelerate therapeutics pipeline in oncology
2024-01-04 03:33:18 ET
More on Evotec SE
- Evotec: Attractive Spec 'Buy', But Merck KGaA Is Still Better
- Evotec SE (EVO) Q3 2023 Earnings Call Transcript
- Evotec SE 2023 Q3 - Results - Earnings Call Presentation
- Evotec partner Jingxin receives approval for EVT201 in China
- Evotec SE reports 9M results
For further details see:
Evotec and Owkin enter AI-powered partnership to accelerate therapeutics pipeline in oncology